Targeting STAT3 Promotes Tumor Cell Death and Enhances T-Cell Activity in HPV16-Positive Cancer.

Saved in:
Bibliographic Details
Title: Targeting STAT3 Promotes Tumor Cell Death and Enhances T-Cell Activity in HPV16-Positive Cancer.
Authors: Prins R; Department of Immunology & Immune Therapeutics, USC/Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA., Fernandez DJ; Department of Immunology & Immune Therapeutics, USC/Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA., Da Silva DM; Department of Obstetrics & Gynecology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA., Turkson J; Division of Medical Oncology, Department of Medicine at Cedars-Sinai, Los Angeles, CA 90048, USA., Lin DC; Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA., Kast WM; Department of Immunology & Immune Therapeutics, USC/Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.; Department of Obstetrics & Gynecology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.; Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.
Source: Cancers [Cancers (Basel)] 2026 Feb 12; Vol. 18 (4). Date of Electronic Publication: 2026 Feb 12.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first